Baxter International Inc
NYSE:BAX

Watchlist Manager
Baxter International Inc Logo
Baxter International Inc
NYSE:BAX
Watchlist
Price: 33.21 USD 0.67% Market Closed
Market Cap: 16.9B USD
Have any thoughts about
Baxter International Inc?
Write Note

Baxter International Inc
Other Items

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Baxter International Inc
Other Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Items CAGR 3Y CAGR 5Y CAGR 10Y
Baxter International Inc
NYSE:BAX
Other Items
$4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Other Items
-$4.8B
CAGR 3-Years
-91%
CAGR 5-Years
N/A
CAGR 10-Years
-32%
Boston Scientific Corp
NYSE:BSX
Other Items
-$2.3B
CAGR 3-Years
-43%
CAGR 5-Years
15%
CAGR 10-Years
-12%
Stryker Corp
NYSE:SYK
Other Items
-$2.2B
CAGR 3-Years
21%
CAGR 5-Years
-5%
CAGR 10-Years
-2%
Abbott Laboratories
NYSE:ABT
Other Items
-$90m
CAGR 3-Years
9%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Intuitive Surgical Inc
NASDAQ:ISRG
Other Items
-$1.8B
CAGR 3-Years
1%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
No Stocks Found

Baxter International Inc
Glance View

Market Cap
16.9B USD
Industry
Health Care

Baxter International Inc. is a global healthcare company that has been a trusted name in the medical sector for over eight decades. Founded in 1931, Baxter specializes in lifesaving medical products and therapies, primarily focusing on renal and hospital care. The company's innovations have revolutionized treatment protocols for conditions such as kidney failure, where their dialysis products are vital for patient care. Additionally, Baxter manufactures a diverse range of infusion systems, biosurgery products, and medications, playing a crucial role in surgical and medical environments. With a commitment to improving patient outcomes, Baxter invests heavily in research and development, which positions it well for future growth, particularly as global healthcare needs continue to expand. As an investor, understanding Baxter’s strategic position in the healthcare industry is key. The company enjoys a robust financial footing, bolstered by its extensive product portfolio and a global distribution network that spans over 100 countries. Recently, Baxter has focused on enhancing its operational efficiency and pursuing strategic acquisitions to broaden its product offerings and enter emerging markets. Moreover, as healthcare systems worldwide prioritize chronic disease management, Baxter’s innovative solutions are increasingly in demand, reinforcing its potential for sustainable revenue growth. In an ever-evolving healthcare landscape, Baxter International Inc. stands out as a formidable player, driven by a mission to save and sustain lives, making it an attractive option for long-term investors looking to enter the healthcare sector.

BAX Intrinsic Value
65.62 USD
Undervaluation 49%
Intrinsic Value
Price

See Also

What is Baxter International Inc's Other Items?
Other Items
4B USD

Based on the financial report for Sep 30, 2024, Baxter International Inc's Other Items amounts to 4B USD.

What is Baxter International Inc's Other Items growth rate?
Other Items CAGR 1Y
2%

Over the last year, the Other Items growth was 2%.

Back to Top